Physician profile
Kent B Berquist
NPI 1134184997
$312.92
in general payments reported to CMS, 2019-2025
10 companies · $80.78 in 2025
The $80.78 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $63.88 · 2020: $37.25 · 2022: $13.90 · 2023: $24.15 · 2024: $92.96 · 2025: $80.78.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $120 · Food and Beverage: $77.91.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $119.98 |
| Food and Beverage | $77.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $119.98 | 2024-2025 | |
| Genzyme Corporation | $68.38 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $37.95 | 2019-2022 | |
| Allergan, INC. | $14.13 | 2019 | |
| Boston Scientific Corporation | $13.66 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $13.21 | 2019 | |
| Glaxosmithkline, LLC. | $12.49 | 2019 | |
| Mylan Specialty L.P. | $12.18 | 2020 | |
| Sunovion Pharmaceuticals INC. | $11.41 | 2020 | |
| 3b Medical, INC. | $9.53 | 2023 | Luna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kent Berquist listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.